FDA Person
FDARichard A. Quaresima
View detailed information about Richard A. Quaresima, including compliance records, violations, and related data.
Person Profile
Comprehensive profile of Richard A. Quaresima, including their role, qualifications, and regulatory activities.
Recent Records (63)
Page 1 of 4WARNING_LETTER - Santiste Labs LLC
WARNING_LETTER
WARNING_LETTER - www.outoftheboxremedies.com
WARNING_LETTER
WARNING_LETTER - Hopewell Essential Oils
WARNING_LETTER
WARNING_LETTER - organic-beauty-recipes.com
WARNING_LETTER
WARNING_LETTER - Carahealth
WARNING_LETTER
WARNING_LETTER - Corona-cure.com
WARNING_LETTER
WARNING_LETTER - Dr. Sherrill Sellman
WARNING_LETTER
WARNING_LETTER - Natural Solutions Foundation
WARNING_LETTER
WARNING_LETTER - Copper Touch, LLC
WARNING_LETTER
WARNING_LETTER - StayWell Copper Products
WARNING_LETTER
WARNING_LETTER - Musthavemom.com
WARNING_LETTER
WARNING_LETTER - Careful Cents, LLC
WARNING_LETTER
WARNING_LETTER - Alternavita
WARNING_LETTER
WARNING_LETTER - CBD Gaze
WARNING_LETTER
WARNING_LETTER - nova botanix ltd
WARNING_LETTER
WARNING_LETTER - The Art Of Cure
WARNING_LETTER
WARNING_LETTER - xephyr, llc
WARNING_LETTER
WARNING_LETTER - the gbs
WARNING_LETTER
WARNING_LETTER - North Coast Biologics
WARNING_LETTER
WARNING_LETTER - Colloidal Vitality LLC/Vital Silver
WARNING_LETTER
Showing 1-20 of 63 records
Person Information
Name
Richard A. Quaresima
ID: d0be06fa-21e5-46d0-879d-95af9663066c
Get More Insights
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox